Loading clinical trials...
Loading clinical trials...
Objective The objective is to recruit antipsychotic-naïve patients at the first diagnosis with a first-episode schizophrenia disorder (FES) to study ketone metabolism of the brain via PET neuroimaging...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ole Köhler-Forsberg
Collaborators
NCT07010614 · Schizophrenia Disorders, Mental Disorder, and more
NCT06641297 · Schizophrenia Disorders
NCT06957808 · Schizophrenia Disorders
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06674694 · Schizophrenia Disorders
Aarhus University Hospital, Psychosis Research Unit
Aarhus
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions